Results: 11
Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".
- Published in:
- Drug Safety, 2022, v. 45, n. 8, p. 925, doi. 10.1007/s40264-022-01207-x
- By:
- Publication type:
- Article
A Review of Causal Inference for External Comparator Arm Studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Developing Strategic Recommendations for Implementing Smart Pumps in Advanced Healthcare Systems to Improve Intravenous Medication Safety.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).
- Published in:
- Drug Safety, 2022, v. 45, n. 8, p. 863, doi. 10.1007/s40264-022-01200-4
- By:
- Publication type:
- Article
Correction to: Machine Learning in Causal Inference: Application in Pharmacovigilance.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Short-Term Risk of Unintentional Poisoning After New Initiation of Central Nervous System Medications in Swedish Older Adults: A Register-Based Case-Crossover Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Combining Machine Learning with a Rule-Based Algorithm to Detect and Identify Related Entities of Documented Adverse Drug Reactions on Hospital Discharge Summaries.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database.
- Published in:
- Drug Safety, 2022, v. 45, n. 8, p. 891, doi. 10.1007/s40264-022-01194-z
- By:
- Publication type:
- Article